Logo

Third Wave Closes $14.9M Convertible Notes Placement

Dec 21, 2006
NEW YORK (GenomeWeb News) — Third Wave Technologies has pocketed $14.9 million after closing the sale of its previously announced zero-coupon convertible notes, the company said today.
 
Third Wave said it intends to use the cash infusion for general corporate expenses.
 
Third Wave said it would place the notes with an unnamed institutional investor on Dec. 19.
 
The 6-percent notes, which are convertible into roughly 2.5 million shares, will be due in 2011 and are priced at an initial rate of $6 apiece.
Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.